Since introduction of wild type p53 activity in mutant p53 harboring cancer cells causes their growth arrest/apoptosis, the anticancer therapies targeting mutant p53/ activation of wild type p53 function have been considered as a valid and effective drug discovery approach. Here, TP53 is linked to cancer.